Burhan Ferhanoğlu

17PUBLICATIONS
123CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 17, 2025
Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B-cell lymphoma cohort.

Umut Yılmaz, Esra Terzi Demirsoy, Fatma Keklik Karadağ

|Jun 13, 2025
Tight competition for the first-line treatment of Hodgkin's lymphoma: a comprehensive review of practice-changing developments in recent years.

Umut Yılmaz, Elif Birtaş Ateşoğlu, Burhan Ferhanoğlu

|Oct 28, 2024
Treatment Patterns and Clinical Outcomes in Patients with Hodgkin Lymphoma from Saudi Arabia, Türkiye, and South Africa: Subgroup Analysis from the International Multicenter Retrospective B-HOLISTIC Study

David Brittain, Saad Akhtar, Sylvia Rodrigues

|Sep 13, 2024
A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients.

Özgür Mehtap, Tayfur Toptas, Mehmet S Dal

|Oct 28, 2023
Sequencing novel agents in the treatment of classical Hodgkin lymphoma.

Burhan Ferhanoglu, Murat Ozbalak

|May 22, 2023
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.

Elif Birtas Atesoglu, Zafer Gulbas, Ant Uzay

Pageof 3

Frequent Collaborators

4 joint publications

Olga Meltem Akay

4 joint publications

Ozgur Mehtap

3 joint publications

Murat Ozbalak

3 joint publications

Sevgi Kalayoğlu Beşışık